By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Fresh data on Biotechnology are presented in a new report. According to news reporting out of Beijing, People's Republic of China, by NewsRx editors, research stated, "The quality of life of patients with head and neck squamous cell carcinoma (HNSCC) has been improved because of advances in surgical and radiotherapeutic techniques as well as organ-preservation methods. Despite such progresses, survival rates are dismal because of frequent recurrences, distant metastases and the development of secondary primary tumors."
Our news journalists obtained a quote from the research from Peking University, "Nanoparticles have distinct characteristics such as a high surface/volume ratio and surface charge and size that can be easily modified. Because of such inherent features, nanoparticles are used in imaging, adjuvant radiotherapy, and drug-or gene-delivery. Thus, nanomedicine holds great promise in the diagnosis and treatment of cancer. In the present review, we summarize recent advances in nanomedicine in the diagnosis and treatment of head and neck cancer. We first review the application of inorganic nanoparticles to photo-thermal and magneto-thermal radiotherapy. We also discuss the use of organic nanoparticles in drug-or genedelivery during chemotherapy. We then review the application of inorganic nanoparticles as radiotherapy enhancers."
According to the news editors, the research concluded: "Finally, we address the factors that influence the biodistribution of nanoparticles in vivo."
For more information on this research see: Advances in nanomedicine for head and neck cancer. Frontiers in Bioscience-Landmark, 2014;19():783-788. Frontiers in Bioscience-Landmark can be contacted at: Frontiers In Bioscience Inc, 16471 Scientific Way, Irvine, CA 92618, USA (see also Biotechnology).
Our news journalists report that additional information may be obtained by contacting D.Y. Huang, Peking University, Coll Engn, Dept. of Mat Sci & Engn, Beijing 100871, People's Republic of China. Additional authors for this research include Y.L. Hou, S.M. Yang and R.G. Wang.
Keywords for this news article include: Asia, Biotechnology, Drugs, Beijing, Oncology, Treatment, Chemotherapy, Bioengineering, Cancer Gene Therapy, Head and Neck Cancer, Adjuvant Radiotherapy, Head and Neck Neoplasms, Combined Modality Therapy, People's Republic of China
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC